- Full Year 2023 AddLife AB Earnings Call TranscriptFeb 02, 2024kr65.25Earnings
- Q3 2023 AddLife AB Earnings Call TranscriptOct 26, 2023kr65.25Earnings
- AddLife AB Capital Markets Day TranscriptSep 15, 2023
- Q2 2023 AddLife AB Earnings Call TranscriptJul 14, 2023kr116Earnings
- Q1 2023 AddLife AB Earnings Call TranscriptApr 26, 2023kr98.6Earnings
- Full Year 2022 AddLife AB Earnings Call TranscriptFeb 02, 2023kr108.2Earnings
- Q3 2022 AddLife AB Earnings Call TranscriptOct 27, 2022kr124.2Earnings
- Q2 2022 AddLife AB Earnings Call TranscriptJul 15, 2022kr157.2Earnings
- Q1 2022 AddLife AB Earnings Call TranscriptApr 28, 2022kr263.6Earnings
- Q4 2021 AddLife AB Earnings Call TranscriptFeb 04, 2022kr193.5 (-26.03%)Earnings
- Nine Months 2021 AddLife AB Earnings Call TranscriptOct 22, 2021kr339.6Earnings
- Half Year 2021 AddLife AB Earnings Call TranscriptJul 15, 2021kr282.6 (-5.93%)Earnings
- Q1 2021 AddLife AB Earnings Call TranscriptApr 28, 2021kr213.3Earnings
- AddLife AB acquires Healthcare 21 Group Call TranscriptApr 12, 2021
- AddLife AB Acquisition of Vision Ophthalmology Group GmbH Conference Call TranscriptApr 08, 2021
- Full Year 2020 AddLife AB Earnings Call TranscriptFeb 03, 2021kr145.4Earnings
- Nine Months 2020 AddLife AB Earnings Call TranscriptOct 21, 2020kr145.5 (+3.43%)Earnings
- Half Year 2020 AddLife AB Earnings Call TranscriptJul 17, 2020kr131 (+11.97%)Earnings
- Q1 2020 AddLife AB Earnings Call TranscriptApr 28, 2020kr78.88Earnings
- Full Year 2019 AddLife AB Earnings Call TranscriptFeb 06, 2020kr76 (+3.40%)Earnings
- Half Year 2019 AddLife AB Earnings Call TranscriptJul 12, 2019kr70.75 (-1.74%)Earnings
- Q1 2019 AddLife AB Earnings Call TranscriptMay 10, 2019kr62 (+3.33%)Earnings
Q3 2022 AddLife AB Earnings Call Transcript
()-&
Good morning, everyone, and welcome to the AddLife Third Quarter Conference Call. Presenting today will be Christina Rubenhag, CFO; and myself, Fredrik Dalborg, the CEO since September.
So let's get started with the presentation where we go through some of the highlights. The quarter and the first 9 months of the year, and then we'll open up for questions after that.
So the third quarter was really a growth in a changing market. We saw a growth of 14% in the business, which is pretty strong. We did see, of course, a significant and expected growth in the COVID sales. But as expected and planned, this was compensated by acquired growth. Looking at the organic growth, it was 2% for the quarter. And on the Medtech side, we saw that the organic growth and margins were a little bit lower than expected and primarily driven by low surgery activity during the summer months. We'll get into more of that detail later on.
So the COVID sales dropped by about 50% compared to the same
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)